ALD306
ALD306 is a human monoclonal antibody (mAb) targeting PCSK9. ALD306 can be used in Hypercholesterolaemia research[1].
Product Specifications
Product Name Alternative
ALD309
UNSPSC
12352203
Target
PCSK9
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Smiles
[ALD306]
References & Citations
[1]Pederson S, et al. Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine. Front Immunol. 2021 Oct 25;12:765822.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
Biotin-30213U-01 25 µg
Biotin Anti-Mouse CD122/IL-2RB Antibody (5H4)
Sign In for Pricing
View Details Biotin-30213U-02 100 µg
Biotin Anti-Mouse CD122/IL-2RB Antibody (5H4)
Sign In for Pricing
View Details 
SIPC574Hu01-01 10 µg
Recombinant Neurotensin Receptor 1, High Affinity (NTSR1)
Sign In for Pricing
View Details SIPC574Hu01-02 50 µg
Recombinant Neurotensin Receptor 1, High Affinity (NTSR1)
Sign In for Pricing
View Details SIPC574Hu01-03 200 µg
Recombinant Neurotensin Receptor 1, High Affinity (NTSR1)
Sign In for Pricing
View Details SIPC574Hu01-04 1 mg
Recombinant Neurotensin Receptor 1, High Affinity (NTSR1)
Sign In for Pricing
View Details